Aurora Cannabis faces headwinds as Q4/FY2025 revenues grow but profitability declines due to one-time expenses. Check out why ...

Aurora CEO says medical cannabis is profitable and growing—even if investors aren't seeing it yet. Here's what's driving the strategy.

Aurora Cannabis sees record Q4-2025 revenues driven by international sales, but low profits and weak 2026 outlook keep stock ...

Empowering Canadian innovation—discover, invest, and grow with homegrown tech leaders shaping the future. The 2025 Cantech ...

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aurora Cannabis Inc. - ACB Provided by GlobeNewswire Jun 28, 2025, 2:00:00 PM.

Aurora Cannabis (ACB) announced that it has become aware of “a second instance of misinformation” posted on news website Investing.com. On June 18, Aurora advised the market that an article posted on ...

Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has become aware of a second instance of misinformation posted on ...

Q4 2025 Earnings Call Transcript June 18, 2025 Aurora Cannabis Inc. misses on earnings expectations. Reported EPS is $0.07 ...

An Edmonton-based cannabis company is cleaning up a mess left behind by an investing site that erroneously published ...

-Aurora Cannabis Inc., the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its fourth quarter and fiscal ...